Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging

In the last decade, PET-only systems have been phased out and replaced with PET-CT systems. This merger of a functional and anatomical imaging modality turned out to be extremely useful in clinical practice. Currently, PET-CT is a major diagnostic tool in oncology. At the dawn of the merger of MRI and PET, another breakthrough in clinical imaging is expected. The combination of these imaging modalities is challenging, but has particular features such as imaging biological processes at the same time in specific body locations.

[1]  Victor J. Sank,et al.  POTENTIAL ADVANTAGES OF A CESIUM FLUORIDE SCINTILLATOR FOR A TIME‐OF‐FLIGHT POSITRON CAMERA , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  T. Budinger.  Time-of-flight positron emission tomography: status relative to conventional PET. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[4]  M E Phelps,et al.  Whole-body positron emission tomography: Part I. Methods and performance characteristics. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  C. K. Hoh,et al.  Positron emission tomography as a diagnostic tool in oncology , 1998, European Radiology.

[6]  M E Phelps,et al.  Positron emission tomography provides molecular imaging of biological processes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Cherry,et al.  Combining anatomy and function: the path to true image fusion , 2001, European Radiology.

[8]  M. Spieth,et al.  A tabulated summary of the FDG PET literature. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  G. V. von Schulthess,et al.  PET/CT of the abdomen: optimizing the patient breathing pattern , 2003, European Radiology.

[10]  Cyrill Burger,et al.  Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner , 2003, European Radiology.

[11]  Mathias K. Fehr,et al.  Follow-up of women with breast cancer: comparison between MRI and FDG PET , 2003, European Radiology.

[12]  Gustav K. von Schulthess,et al.  Clinical evaluation of a breathing protocol for PET/CT , 2004, European Radiology.

[13]  PET/CT in Colorectal Cancer. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  L. Blomqvist,et al.  Whole-body imaging with MRI or PET/CT: the future for single-modality imaging in oncology? , 2003, JAMA.

[15]  Thomas Beyer,et al.  X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. , 2003, Seminars in nuclear medicine.

[16]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[17]  Heiko Schöder,et al.  PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  G. Antoch,et al.  Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer , 2004, European Radiology.

[19]  Richard L Wahl,et al.  Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  G. Antoch,et al.  Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer. , 2004, European radiology.

[21]  M. Phelps,et al.  Performance of 2-Deoxy-2-[F-18]fluoro-d-glucose Positron Emission Tomography and Integrated PET/CT in Restaged Breast Cancer Patients , 2005, Molecular Imaging and Biology.

[22]  Barry A. Siegel,et al.  Oncologic PET/CT: current status and controversies , 2005, European radiology.

[23]  P. Wust,et al.  Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging? , 2005, European Radiology.

[24]  Gerald Antoch,et al.  False-Positive FDG PET Uptake−the Role of PET/CT , 2006, European Radiology.

[25]  M C Gilardi,et al.  PET/CT and radiotherapy. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[26]  P. Ell,et al.  The contribution of PET/CT to improved patient management. , 2006, The British journal of radiology.

[27]  D. Visvikis,et al.  The role of PET/CT scanning in radiotherapy planning. , 2006, The British journal of radiology.

[28]  Thomas F Hany,et al.  Integrated PET/CT: current applications and future directions. , 2006, Radiology.

[29]  S. Schoenberg,et al.  Whole-body MRI and PET-CT in the management of cancer patients , 2006, European Radiology.

[30]  Ora Israel,et al.  The role of FDG‐PET/CT in suspected recurrence of breast cancer , 2006, Cancer.

[31]  Ciprian Catana,et al.  Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  D. Podoloff,et al.  PET and PET/CT in management of the lymphomas. , 2007, Radiologic clinics of North America.

[33]  T. Beyer,et al.  FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy. , 2007, The British journal of radiology.

[34]  C. Meltzer,et al.  PET/CT: form and function. , 2007, Radiology.

[35]  G. Antoch,et al.  Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer , 2007, European Radiology.

[36]  Thomas F Hany,et al.  High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases. , 2007, Radiology.

[37]  R. Wahl,et al.  Integrating PET and PET/CT into the risk-adapted therapy of lymphoma. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  M. Langer,et al.  Detection of recurrent rectal cancer with CT, MRI and PET/CT , 2007, European Radiology.

[39]  G. Antoch,et al.  Whole-body PET/CT-colonography: a possible new concept for colorectal cancer staging , 2007, Abdominal Imaging.

[40]  Ciprian Catana,et al.  Simultaneous PET-MRI: a new approach for functional and morphological imaging , 2008, Nature Medicine.

[41]  Bernd J. Pichler,et al.  PET/MRI hybrid imaging: devices and initial results , 2008, European Radiology.

[42]  K. Sugimura,et al.  Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer , 2008, European Radiology.

[43]  Jin Hwan Kim,et al.  CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck , 2009, European Radiology.

[44]  S. de Vos,et al.  The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients. , 2008, Radiologic clinics of North America.

[45]  M. Reiser,et al.  Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer , 2009, European Radiology.

[46]  Thomas C. Kwee,et al.  Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis , 2008, European Radiology.

[47]  P. Grigsby.  The prognostic value of PET and PET/CT in cervical cancer , 2008, Cancer imaging : the official publication of the International Cancer Imaging Society.

[48]  Johan Nuyts,et al.  1-11C-Acetate Kinetics of Prostate Cancer , 2008, Journal of Nuclear Medicine.

[49]  Bernhard Schölkopf,et al.  MRI-Based Attenuation Correction for PET/MRI: A Novel Approach Combining Pattern Recognition and Atlas Registration , 2008, Journal of Nuclear Medicine.

[50]  M. Schwaiger,et al.  Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer , 2009, Journal of oncology.

[51]  Zhen J. Wang,et al.  18F-FDG PET/CT of transitional cell carcinoma. , 2009, AJR. American journal of roentgenology.

[52]  W. Murphy,et al.  Musculoskeletal pitfalls in 18F-FDG PET/CT: pictorial review. , 2009, AJR. American journal of roentgenology.

[53]  Rakesh Kumar,et al.  The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer , 2009, European Radiology.

[54]  R. Hustinx,et al.  PET/CT in head and neck cancer: an update , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[55]  D. Vriens,et al.  Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review , 2009, Journal of Nuclear Medicine.

[56]  N. Holalkere,et al.  Evaluation of the effects of oral water and low-density barium sulphate suspension on bowel appearance on FDG-PET/CT , 2009, European Radiology.

[57]  N. Smeeton,et al.  Observer Variation in Interpreting 18F-FDG PET/CT Findings for Lymphoma Staging , 2009, Journal of Nuclear Medicine.

[58]  Ellen Yorke,et al.  18F-FDG PET/CT for Image-Guided and Intensity-Modulated Radiotherapy* , 2009, Journal of Nuclear Medicine.

[59]  A. Scarsbrook,et al.  PET/CT in primary musculoskeletal tumours: a step forward , 2010, European Radiology.

[60]  Sven Kabus,et al.  Combined correction of recovery effect and motion blur for SUV quantification of solitary pulmonary nodules in FDG PET/CT , 2010, European Radiology.

[61]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[62]  Heinz-Peter Schlemmer,et al.  PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications , 2010, Journal of Nuclear Medicine.

[63]  Priyanka Prakash,et al.  Role of PET/CT in ovarian cancer. , 2010, AJR. American journal of roentgenology.

[64]  T. Yen,et al.  Comprehensive imaging of residual/recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT , 2010, European Radiology.

[65]  W. Vogel,et al.  Utility of Preoperative 18F-FDG PET/CT and Brain MRI in Melanoma Patients with Palpable Lymph Node Metastases , 2010, Annals of Surgical Oncology.

[66]  T. Beyer,et al.  PET versus PET/CT dual-modality imaging in evaluation of lung cancer. , 2010, Thoracic surgery clinics.

[67]  Matthias Hofmann,et al.  Hybrid PET/MRI of Intracranial Masses: Initial Experiences and Comparison to PET/CT , 2010, The Journal of Nuclear Medicine.

[68]  H. Minn,et al.  Impact of PET/CT on planning of radiotherapy in head and neck cancer. , 2010, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[69]  Dominik Weishaupt,et al.  Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT , 2011, European Radiology.

[70]  P. Grigsby,et al.  Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  T. Turkington,et al.  A systematic review of the factors affecting accuracy of SUV measurements. , 2010, AJR. American journal of roentgenology.